Supply of Atorvastatin Calcium 80 MG Tablets

The contract entails the annual supply of 6,633 bottles, each containing 90 tablets of Atorvastatin Calcium 80 MG, totaling nearly 600,000 tablets per year for a five-year period. This high-dose statin is intended for cholesterol management and will be procured under a subcontract arrangement by the Department of Defense through its Medical Supply Chain FSGB. The solicitation was posted on July 13, 2026, with a response deadline set for August 13, 2026, indicating an active procurement cycle targeting manufacturers or distributors capable of meeting the volume and quality requirements. The NAICS code 325412 confirms the involvement of pharmaceutical manufacturing, and while specific delivery locations are not detailed, performance is expected to align with federal supply chain protocols under DOD oversight. The absence of a set-aside designation suggests open competition among qualified vendors.